-Alvaro N A Monteiro Researcher Activity Profile

Research Author Detailed Information 

Alvaro N A Monteiro Publication Rate By Year

Alvaro N A Monteiro has published 2 paper(s) in 2006, 6 paper(s) in 2007, for a total of 8 research publications in total.

Alvaro N A An Monteiro Author Information

LAST NAME: monteiro

FIRST NAME: Alvaro N A

INITIALS: an

AFFILIATION:

Papers

Alvaro N A Monteiro's Publication Record

1. Functional implications of BRCA1 for early detection, prevention, and treatment of breast cancer. Year Published: 2006
Risk Assessment, Detection and Intervention Program, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.
2. Functional assays for BRCA1 and BRCA2. Year Published: 2006
Department of Risk Assessment, Detection, and Intervention, H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, USA.
3. Determination of cancer risk associated with germ line BRCA1 missense variants by functional analysis. Year Published: 2007
Risk Assessment, Detection, and Intervention Program, H. Lee Moffitt Cancer Center, University of South Florida College of Medicine, 12902 Magnolia Drive, Tampa, FL 33612, USA.
4. A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes. Year Published: 2007
Genetic Epidemiology Unit, Strangeways Research Laboratories, University of Cambridge, Cambridge, UK. david.goldgar@hsc.utah.edu
5. Functional impact of missense variants in BRCA1 predicted by supervised learning. Year Published: 2007
Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland, United States of America. karchin@karchinlab.org
6. Year Published: 2007
Risk Assessment, Detection, and Intervention Program, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA; Department of Interdisciplinary Oncology, College of Medicine, University of South Florida, Tampa, Florida, USA.
7. A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes. Year Published: 2007
Genetic Epidemiology Unit, Strangeways Research Laboratories, University of Cambridge, Cambridge, UK. david.goldgar@hsc.utah.edu
8. Year Published: 2007
Risk Assessment, Detection, and Intervention Program, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA. monteian@moffitt.usf.edu